TULSA, OK / ACCESSWIRE / December 9, 2020 / (OTC PINK:LVGI) Limitless Venture Group, Inc. ("LVGI" or "the Company") today...
CAVE CREEK, AZ / ACCESSWIRE / December 9, 2020 / Dr. Jeff Comer, a successful leader in the Alaska healthcare...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...
STUART, FL / ACCESSWIRE / December 9, 2020 / Prescription Hope, one of the largest patient assistance program administrators in...
Company Achieves Rare Milestone in Cannabis Industry DENVER, CO / ACCESSWIRE / December 9, 2020 / Leafbuyer Technologies, Inc. ("Leafbuyer"...
aGvHD among potential indications being considered for next stage of development Candidate to move to IND-enabling studies in 2021 RALEIGH,...
The Companies will work together to bring Chemesis' AI retail solution to Portland, Oregon VANCOUVER, BC / ACCESSWIRE / December...
Powered by Zylö's patented Xerogel Silica Gel ("Z-Pod™") delivery system, Grapefruit's Patented Hourglass™ THC + Cannabinoid Topical Cream is the...
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Broad and deep portfolio of highly differentiated product candidates aligned with needs of patients and doctorsRobust pipeline includes 4 development...
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...
– Data demonstrate potential of Amunix’s XPAT (XTENylated Protease-Activated T cell engager) platform to mitigate on-target, off-tumor toxicity that has...
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with unrivaled OS evidence1Kisqali plus endocrine therapy had...
FDA has granted clearance for the commencement of Phase 1 clinical trials of STI-2020 (COVI-AMGTM) in healthy volunteers and COVID-19...
Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint...
–EDP1908 announced as clinical candidate in oncology after showing superior preclinical activity over EDP1503––Interim clinical data for EDP1503 suggest potential...
VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
The Ellume COVID-19 Home Test App The Ellume COVID-19 Home Test connects directly to users’ smartphone, providing for step-by-step instructions...
SEATTLE, Dec. 09, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs...